Publications by authors named "Navin Pinto"

29Publications

Extensive small bowel pneumatosis and ischemia during dinutuximab therapy for high-risk neuroblastoma.

Pediatr Blood Cancer 2020 04 11;67(4):e28147. Epub 2020 Jan 11.

Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28147DOI Listing
April 2020

Acute enlargement of a vascular plaque and gait changes in a young girl.

BMJ 2018 Nov 28;363:k4679. Epub 2018 Nov 28.

Division of Dermatology, Department of Pediatrics, University of Washington School of Medicine and Seattle Children's Hospital; Seattle, WA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.k4679DOI Listing
November 2018

Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources.

J Glob Oncol 2018 09;4:1-12

Mahmoud M. Elzembely, Paul A. Carpenter, and K. Scott Baker, Fred Hutchinson Cancer Research Center; Julie R. Park, Navin Pinto, Paul A. Carpenter, and K. Scott Baker, University of Washington; Julie R. Park, Navin Pinto, Paul A. Carpenter, and K. Scott Baker, Seattle Children's Hospital, Seattle WA; Mahmoud M. Elzembely, Khaled F. Riad, and Heba A. Sayed, South Egypt Cancer Institute, Assiut University, Assiut; Alaa El-Haddad, El-Sheikh Zayed Specialized Hospital; Alaa El-Haddad, 57357 Children's Cancer Hospital; and Alaa El-Haddad, Cairo University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.17.00118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223425PMC
September 2018

Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue.

Pediatr Blood Cancer 2019 01 27;66(1):e27421. Epub 2018 Aug 27.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27421DOI Listing
January 2019

A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2018 08 9;82(2):309-317. Epub 2018 Jun 9.

Section of Hematology Oncology, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL, 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3619-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739841PMC
August 2018

Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.

Transfusion 2018 06 13;58(6):1414-1420. Epub 2018 Mar 13.

Center for Clinical and Translational Research, Seattle Children's Hospital and Research Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/trf.14569
Publisher Site
http://dx.doi.org/10.1111/trf.14569DOI Listing
June 2018

Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors.

Pediatr Blood Cancer 2017 Nov 10;64(11). Epub 2017 May 10.

Department of Laboratories, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.26613
Publisher Site
http://dx.doi.org/10.1002/pbc.26613DOI Listing
November 2017

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

Eur J Cancer 2017 02 26;72:177-185. Epub 2016 Dec 26.

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Family Cancer Research Institute, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.11.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258837PMC
February 2017

Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients.

Pediatr Blood Cancer 2017 03 24;64(3). Epub 2016 Sep 24.

Department of Pediatrics, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26226DOI Listing
March 2017

Second Malignant Neoplasms in Rhabdomyosarcoma: Victims of Our Own Success or an Underlying Genetic Predisposition Syndrome?

Pediatr Blood Cancer 2016 Feb 27;63(2):189-90. Epub 2015 Oct 27.

Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25776DOI Listing
February 2016

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

J Clin Oncol 2015 Sep 24;33(27):3008-17. Epub 2015 Aug 24.

Navin R. Pinto, Mark A. Applebaum, Samuel L. Volchenboum, and Susan L. Cohn, Comer Children's Hospital, University of Chicago, Chicago, IL; Katherine K. Matthay, University of California San Francisco (UCSF) Benioff Children's Hospital, UCSF School of Medicine, San Francisco, CA; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Peter F. Ambros, Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria; Akira Nakagawara, Saga Medical Center Koseikan, Saga, Japan; Frank Berthold, Children's Hospital, University of Cologne, Koln, Germany; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; Julie R. Park, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; and Andrew D.J. Pearson, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/27/3008.full.pdf
Web Search
http://200.40.135.66:90/toc/0873/2015/0873-20150920-27-07.pd
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.4648
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.4648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567703PMC
September 2015

Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma.

Pediatr Blood Cancer 2015 Dec 14;62(12):2232-4. Epub 2015 Jul 14.

Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation, Comer Children's Hospital, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25650DOI Listing
December 2015

Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience.

Per Med 2015 Jun;12(3):221-229

Department of Pediatrics, The University of Chicago, 5801 S Ellis Ave, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pme.14.90DOI Listing
June 2015

Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution.

BMC Pharmacol Toxicol 2014 Dec 3;15:69. Epub 2014 Dec 3.

Committee of Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2050-6511-15-69DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287354PMC
December 2014

Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.

Pediatr Blood Cancer 2015 Jan 23;62(1):128-33. Epub 2014 Sep 23.

Departments of Pediatrics, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237647PMC
January 2015

Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.

Pediatr Blood Cancer 2014 Jun 30;61(6):1104-6. Epub 2013 Nov 30.

Department of Pediatrics, Section of Pediatric Hematology/Oncology, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24889DOI Listing
June 2014

Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.

J Natl Cancer Inst 2013 Feb 14;105(4):302-9. Epub 2012 Dec 14.

Section of Genetic Medicine, University of Chicago, 900 E 57th St, Rm 3220F, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691940PMC
February 2013

Using germline genomics to individualize pediatric cancer treatments.

Clin Cancer Res 2012 May;18(10):2791-800

Department of Pediatrics and Medicine, and Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-1938DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354919PMC
May 2012

Clinically relevant genetic variations in drug metabolizing enzymes.

Curr Drug Metab 2011 Jun;12(5):487-97

Section of Hematology/Oncology, Department of Pediatrics, Comprehensive Cancer Center, The University of Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110519PMC
http://dx.doi.org/10.2174/138920011795495321DOI Listing
June 2011

Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.

Pharmacogenomics 2009 Dec;10(12):1897-903

University of Chicago, 900 East 57th Street, Room 7100, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.09.134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820268PMC
December 2009